Supply Of Human Use Medications Whose Active Ingredients Are Mifamurtid, Vedolizumab And Marivabir, Destined For Centers In The Field Of Valencian Public Health.

Name: Supply Of Human Use Medications Whose Active Ingredients Are Mifamurtid, Vedolizumab And Marivabir, Destined For Centers In The Field Of Valencian Public Health.
Start: 2025-05-30
End: -0001-11-30
Location: Direccion General de Gestion Economica, Contratacion e Infraestructuras de la Conselleria de Sanidad

Direccion General de Gestion Economica, Contratacion e Infraestructuras de la Conselleria de Sanidad Spain has Released a tender for Supply Of Human Use Medications Whose Active Ingredients Are Mifamurtid, Vedolizumab And Marivabir, Destined For Centers In The Field Of Valencian Public Health. in Pharmaceuticals. The tender was released on May 30, 2025.

Country - Spain

Summary - Supply Of Human Use Medications Whose Active Ingredients Are Mifamurtid, Vedolizumab And Marivabir, Destined For Centers In The Field Of Valencian Public Health.

Deadline - login to view

GT reference number - 109972387

Product classification - Immunosuppressive agents

Organization Details:

Address - Spain

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 109972387

Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Supply of human use medications whose active ingredients are mifamurtid, Vedolizumab and Marivabir, destined for centers in the field of Valencian public health.local title:: Suministro de medicamentos de uso humano cuyos principios acti vos son Mifamurtida, Vedolizumab y Marivabir, con destino a los centros del ámbito de la Sanidad Pública Valenciana.Contract Type: : Supplylocal description: : Suministro de medicamentos de uso humano cuyos principios activos son Mifamurtida, Vedolizumab y Marivabir, con destino a los centros del ámbito de la Sanidad Pública Valenciana.Gross Budget Euro: : 37832054.4Net Budget Euro: : 9007632.0Gross Budget LC: : 37832054.4Net Budget LC: : 900

Gt Ref Id - 109972387

Deadline - Nov 30, -0001